V. Gopalakrishnan
Molecular Biology · Science · 2016–2021
A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 269 citations into it; #16,811 of 17,773 by trust here, #3,737 by citations
Whom V. Gopalakrishnan trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts V. Gopalakrishnan overall
Papers from V. Gopalakrishnan's perspective
Ordered by how strongly the researchers V. Gopalakrishnan trusts endorse each paper. Same corpus, a different order for every researcher.
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota (Science)
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy (Science)
- Induction of intestinal Th17 cells by segmented filamentous bacteria (Cell)
- Host-Bacterial Mutualism in the Human Intestine (Science)
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (New England Journal of Medicine)
- Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees (Nucleic Acids Res.)
- Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. (Clinical Infectious Diseases)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- Chapter 12: Human Microbiome Analysis (PLoS Comput. Biol.)
- Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- The microbiome, cancer, and cancer therapy (2019) — 1,015 citations
- The human tumor microbiome is composed of tumor type-specific intracellular bacteria (2020) — 2,022 citations
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. (2018) — 1,163 citations
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients (2017) — 4,226 citations
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine (2017) — 1,535 citations
- Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response (2021) — 793 citations
- B cells and tertiary lymphoid structures promote immunotherapy response (2020) — 2,250 citations
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma (2018) — 754 citations
- Defining T cell states associated with response to checkpoint immunotherapy in melanoma (2018) — 1,832 citations
- Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis (2018) — 653 citations
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance (2017) — 775 citations
- Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade (2016) — 871 citations